Rylaze 10 mg/0.5 mL injection Images
Generic Name: asparaginase erwinia chrysanthemi
This medication has been identified as Rylaze 10 mg/0.5 mL injection and is used for Acute Lymphoblastic Leukemia. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.
Images of medication
Rylaze
- Generic Name
- asparaginase erwinia chrysanthemi
- Strength
- 10 mg/0.5 mL injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jazz Pharmaceuticals plc
- National Drug Code (NDC)
- 68727-0900
See also:
More about Rylaze (asparaginase erwinia chrysanthemi)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.